Endocyte receives $3.5 million for cancer treatments

11/17/2004 | Journal Gazette (Fort Wayne, Ind.), The

Endocyte, a biotech company involved in chemotherapeutics aimed at cancer cells, has been awarded $3.5 million in federal and state grants to finish research expected to lead to clinical trials. The West Lafayette, Ind., company hopes to be able to stimulate cancer cells to take in vitamin foliate molecules treated with anti-cancer drugs, allowing the treatment to avoid harming normal cells.

View Full Article in:

Journal Gazette (Fort Wayne, Ind.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA